References
- Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr. 2008;28:115-30. doi: 10.1146/annurev.nutr.28.061807.155443
- Kirkland JB. Niacin requirements for genomic stability. Mutat Res. 2012;733:14-20. doi: 10.1016/j.mrfmmm.2011.11.008. PMID:22138132
- Bruzzone S, Daniele Parenti M, Grozio A, Ballestrero A, Bauer I, Del Rio A, Nencioni A. Rejuvenating sirtuins: The rise of a new family of cancer drug targets. Curr Pharm Des. 2013;19:614-23. doi: 10.2174/138161213804581954. PMID:23016857
- Piacente F, Caffa I, Ravera S, Sociali G, Passalacqua M, Vellone VG, Becherini P, Reverberi D, Monacelli F, Ballestrero A, Odetti P, Cagnetta A, Cea M, Nahimana A, Duchosal M, Bruzzone S, Nencioni A. Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors, and DNA repair. Cancer Res. 2017;77(14):3857-69. pii: canres.3079.2016. doi: 10.1158/0008-5472.CAN-16-3079. PMID:28507103
- Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics Data. Cancer Discov. 2012;2:401-4. doi: 10.1158/2159-8290.CD-12-0095. PMID:22588877
- Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016;16:110-20. doi: 10.1038/nrc.2015.21. PMID:26775620
- Gaut ZN, Solomon HM. Inhibition of nicotinate phosphoribosyltransferase in human platelet lysate by nicotinic acid analogs. Biochem Pharmacol. 1971; 20:2903-6. doi: 10.1016/0006-2952(71)90202-4. PMID:4255930